MUMBAI, India, July 25 -- Intellectual Property India has published a patent application (202517049063 A) filed by Xiamen University; and Xiamen Innovax Biotech Co. Ltd., Fujian, China, on May 21, for 'fusion protein and granulated antigen comprising same.'
Inventor(s) include Li, Shaowei; Li, Tingting; Xue, Wenhui; Deng, Tingting; Fang, Qianjiao; Gu, Ying; Zhang, Jun; and Xia, Ningshao.
The application for the patent was published on July 25, under issue no. 30/2025.
According to the abstract released by the Intellectual Property India: "Provided are a fusion protein and a composition, a kit, a granulated antigen, a vaccine, and a pharmaceutical composition comprising same. The present invention also relates to use of the fusion protein and the composition, the kit, and the granulated antigen comprising same in the preparation of a pharmaceutical composition or a vaccine. The granulated antigen is particularly suitable for the production and vaccination of a vaccine and has advantages in the prevention and/or treatment of viral infections."
The patent application was internationally filed on Nov. 06, 2023, under International application No.PCT/CN2023/129973.
Disclaimer: Curated by HT Syndication.
